Cargando…
Feasibility of next‐generation sequencing test for patients with advanced NSCLC in clinical practice
BACKGROUND: The usefulness of the Oncomine Dx Target test (Oncomine Dx), a next‐generation sequencing (NGS) test, has already been proven in clinical trials. However, NGS requires high‐quality tumor samples and takes a long time to generate results. The feasibility of NGS for use in advanced non‐sma...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882378/ https://www.ncbi.nlm.nih.gov/pubmed/33350072 http://dx.doi.org/10.1111/1759-7714.13786 |